M. Milano

发表

Local control rates with five-fraction stereotactic body radiotherapy for oligometastatic cancer to the lung.

Deepinder P. Singh, M. Schell, Yuhchyau Chen, 2014, Journal of thoracic disease.

Single- and Multi-Fraction Stereotactic Radiosurgery Dose Tolerances of the Optic Pathways.

Issam El Naqa, Lijun Ma, Ellen Yorke, 2018, International journal of radiation oncology, biology, physics.

Hypofractionated stereotactic body radiation therapy (SBRT) for limited hepatic metastases.

M. Schell, A. Muhs, P. Okunieff, 2007, International journal of radiation oncology, biology, physics.

Long‐term cause‐specific mortality in survivors of adolescent and young adult bone and soft tissue sarcoma: A population‐based study of 28,844 patients

L. Constine, L. Travis, M. Milano, 2014, Cancer.

Survivors of Childhood Hodgkin’s Lymphoma After Treatment: Subsequent Solid Tumor Malignancies Based on Gender and Radiation Dose

L. Constine, M. Milano, P. Youn, 2013 .

Central thoracic lesions treated with hypofractionated stereotactic body radiotherapy.

M. Schell, Yuhchyau Chen, P. Okunieff, 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Severe radiation-induced leukoencephalopathy: Case report and literature review

K. Walter, N. Mohile, K. Usuki, 2016, Advances in radiation oncology.

Tumor Control Probability of Radiosurgery and Fractionated Stereotactic Radiosurgery for Brain Metastases.

E. Yorke, D. Heron, I. El Naqa, 2020, International journal of radiation oncology, biology, physics.

Single-Fraction Radiosurgery Using Conservative Doses for Brain Metastases: Durable Responses in Select Primaries With Limited Toxicity

P. Okunieff, M. Schell, K. Walter, 2018, Neurosurgery.

Oligometastatic breast cancer treated with curative-intent stereotactic body radiation therapy

A. Muhs, P. Okunieff, Hong Zhang, 2009, Breast Cancer Research and Treatment.

Chapter 25 – Metastatic Disease: Bone, Spinal Cord, Brain, Liver, and Lung

P. Okunieff, K. Usuki, M. Milano, 2016 .

Targeting Vitamin-D receptor (VDR) by a small molecule antagonist MeTC7 inhibits PD-L1 but controls THMYCN neuroblastoma growth PD-L1 independently

Richard G. Moore, S. Gerber, J. Hansen, 2020, bioRxiv.

Reirradiation of recurrent and second primary head and neck malignancies: a comprehensive review.

D. Haraf, J. Kao, M. Milano, 2003, Cancer treatment reviews.

Twice-daily reirradiation for recurrent and second primary head-and-neck cancer with gemcitabine, paclitaxel, and 5-fluorouracil chemotherapy.

R. Weichselbaum, E. Vokes, A. Argiris, 2005, International journal of radiation oncology, biology, physics.

gamma-H2AX as a therapeutic target for improving the efficacy of radiation therapy.

R. Weichselbaum, J. Kao, A. Javaheri, 2006, Current cancer drug targets.

Simple Factors Associated With Radiation-Induced Lung Toxicity After Stereotactic Body Radiation Therapy of the Thorax: A Pooled Analysis of 88 Studies.

E. Yorke, X. Li, J. Zhao, 2016, International journal of radiation oncology, biology, physics.

The correlation of fractional anisotropy parameters with Ki-67 index, and the clinical implication in grading of non-enhancing gliomas and neuronal-glial tumors.

Mahlon D. Johnson, Xiang Liu, S. Ekholm, 2019, Magnetic resonance imaging.

Long-term survival among patients with Hodgkin's lymphoma who developed breast cancer: a population-based study.

M. Gail, L. Constine, L. Travis, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The integration of cancer survivorship training in the curriculum of hematology/oncology fellows and radiation oncology residents

L. Constine, M. Milano, E. Culakova, 2014, Journal of Cancer Survivorship.

Phase I Study of Concomitant Chemoradiotherapy with Irinotecan, 5‐FU., and Hydroxyurea for Patients with Advanced and/or Recurrent Head and Neck Cancer

D. Haraf, K. Stenson, M. Milano, 2005, Cancer journal.

Stereotactic body radiotherapy for pulmonary metastases from soft-tissue sarcomas: excellent local lesion control and improved patient survival.

L. Constine, M. Milano, Carolyn E. Jones, 2010, International journal of radiation oncology, biology, physics.

Descriptive analysis of oligometastatic lesions treated with curative-intent stereotactic body radiotherapy.

M. Schell, P. Okunieff, M. Milano, 2008, International journal of radiation oncology, biology, physics.

Nivolumab without brain radiotherapy is insufficient for the treatment of most patients with brain metastases from clear cell renal cell carcinoma.

M. Milano, A. Chowdhry, S. Hardy, 2019, Annals of translational medicine.

Is “watch and wait” a viable option for surgically resected brain metastases?

John Kang, M. Milano, 2018 .

Radiation Therapy in the Management of Patients With Limited Brain Metastases

M. Milano, S. Dhakal, C. R. Peterson, 2014, American journal of clinical oncology.

Meningioma in Breast Cancer Patients: Population-based Analysis of Clinicopathologic Characteristics

M. Milano, C. Grossman, 2017, American journal of clinical oncology.

Local control rates with five fractions of stereotactic body radiotherapy for primary lung tumors: a single institution experience of 153 consecutive patients

Deepinder P. Singh, M. Schell, Yuhchyau Chen, 2015 .

Hypofractionated Stereotactic Radiotherapy for Non-breast or Prostate Cancer Oligometastases: A Tail of Survival Beyond 10 Years

Deepinder P. Singh, P. Okunieff, M. Milano, 2019, Front. Oncol..

Analysis of patients with oligometastases undergoing two or more curative-intent stereotactic radiotherapy courses.

P. Okunieff, M. Milano, A. Philip, 2009, International journal of radiation oncology, biology, physics.

Stereotactic Body Radiation Therapy (SBRT) for lung metastases

Abraham Philip, M. Schell, P. Okunieff, 2006, Acta oncologica.

Three‐ Versus Five‐Fraction Regimens of Stereotactic Body Radiotherapy for Peripheral Early‐Stage Non–Small‐Cell Lung Cancer: A Two‐Institution Propensity Score–Matched Analysis

Lucas M. Serra, Deepinder P. Singh, Anurag K. Singh, 2017, Clinical lung cancer.

Comparison of Single‐ and Five‐fraction Regimens of Stereotactic Body Radiation Therapy for Peripheral Early‐stage Non–small‐cell Lung Cancer: A Two‐institution Propensity‐matched Analysis

Lucas M. Serra, Deepinder P. Singh, Anurag K. Singh, 2018, Clinical lung cancer.

Chest Wall Toxicity After Stereotactic Body Radiation Therapy: A Pooled Analysis of 57 Studies.

F. Kong, M. Milano, Jie-tao Ma, 2017, International journal of radiation oncology, biology, physics.

Evaluation of Safety of Stereotactic Body Radiotherapy for the Treatment of Patients With Multiple Metastases: Findings From the NRG-BR001 Phase 1 Trial.

Sean S. Park, H. Al-Hallaq, T. Pisansky, 2021, JAMA oncology.

Oligometastases: history of a hypothesis.

S. Lo, M. Milano, T. Biswas, 2020, Annals of palliative medicine.

Stereotactic body radiation therapy versus metastasectomy for oligometastases.

M. Milano, A. Katz, H. Qiu, 2019, Journal of thoracic disease.

Pulmonary metastectomy: impact of tumor histology and size.

Michal J. Lada, M. Milano, Carolyn E. Jones, 2018, Journal of thoracic disease.

Survival after subsequent non-Hodgkin's lymphoma and non-small cell lung cancer in patients with malignant thymoma.

M. Milano, S. Dhakal, J. S. Parzen, 2016, Journal of thoracic disease.

Pediatric Normal Tissue Effects in the Clinic (PENTEC): An International Collaboration to Assess Normal Tissue Radiation Dose-Volume-Response Relationships for Children With Cancer.

E. Yorke, C. Ronckers, M. Hudson, 2021, International journal of radiation oncology, biology, physics.

Chapter 23 – Metastatic Disease: Bone, Spinal Cord, Brain, Liver, and Lung

A. Porter, P. Okunieff, M. Milano, 2012 .

Myxopapillary ependymoma: a SEER analysis of epidemiology and outcomes

M. Milano, J. Bates, Gyujae Choi, 2016, Journal of Neuro-Oncology.

Second primary head and neck cancer after Hodgkin lymphoma: A population‐based study of 44,879 survivors of Hodgkin lymphoma

L. Constine, C. Fung, M. Milano, 2015, Cancer.

Repeat courses of SRS in patients initially treated with SRS alone for brain-metastatic melanoma.

K. Usuki, M. Milano, P. Youn, 2016, Melanoma management.

Executive Summary from American Radium Society's Appropriate Use Criteria on Neurocognition after stereotactic radiosurgery for multiple brain metastases.

A. Garg, J. Knisely, S. Lo, 2020, Neuro-oncology.

Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinoma.

E. Vokes, D. Haraf, J. Kao, 2006, International journal of radiation oncology, biology, physics.

Immunotherapy with hypofractionated radiotherapy in metastatic non-small cell lung cancer: An analysis of the National Cancer Database.

A. Yeung, M. Milano, C. Morris, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Should We Target Oligometastatic EGFR-Mutated NSCLC with Radiotherapy before Administering Targeted Systemic Therapy?

M. Milano, S. Chmura, J. Salama, 2022, Journal of the National Cancer Institute.

Phase I Study of Concomitant Chemoradiotherapy with Paclitaxel, Fluorouracil, Gemcitabine, and Twice-Daily Radiation in Patients with Poor-Prognosis Cancer of the Head and Neck

E. Vokes, A. Argiris, D. Haraf, 2004, Clinical Cancer Research.

Increased risk of high-grade prostate cancer among testicular cancer survivors

E. Messing, Yuhchyau Chen, C. Fung, 2022, PloS one.

Intensity‐modulated radiotherapy and the Internet

J. Roeske, L. Mell, A. Mundt, 2004, Cancer.

Incidental brain lesions in children: to treat or not to treat?

L. Constine, H. Silberstein, D. Korones, 2012, Journal of Neuro-Oncology.

Reducing Radiation-Induced Cognitive Toxicity: Sparing the Hippocampus and Beyond.

S. Soltys, K. Redmond, D. Trifiletti, 2021, International journal of radiation oncology, biology, physics.

Reirradiation of recurrent head and neck cancers with curative intent.

D. Haraf, M. Milano, S. Chmura, 2004, Seminars in oncology.

Predicting intracranial progression following stereotactic radiosurgery for brain metastases: Implications for post SRS imaging.

K. Choudhury, J. Kirkpatrick, J. Adamson, 2019, Journal of radiosurgery and SBRT.

Squamous cell carcinoma of the head and neck with unknown primary: trends and outcomes from a hospital-based registry

Deepinder P. Singh, Anurag K. Singh, M. Milano, 2021, Annals of translational medicine.

Malignant Pleural Mesothelioma: A Population-Based Study of Survival

Hong Zhang, M. Milano, 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Oligometastases treated with stereotactic body radiotherapy: long-term follow-up of prospective study.

P. Okunieff, Hong Zhang, M. Milano, 2012, International journal of radiation oncology, biology, physics.

Stereotactic Body Radiotherapy for Lung Metastases from Colorectal Cancer: Prognostic Factors for Disease Control and Survival

Deepinder P. Singh, Yuhchyau Chen, P. Okunieff, 2015, American journal of clinical oncology.

Oligometastases to the liver: predicting outcomes based upon radiation sensitivity.

M. Milano, A. Katz, H. Qiu, 2016, Journal of thoracic disease.

American Radium Society™ Appropriate Use Criteria: Neurocognition after stereotactic radiosurgery for multiple brain metastases Expert Panel on Brain Malignancies

A. Garg, S. Lo, A. Sahgal, 2022 .

An individual patient data metaanalysis of outcomes and prognostic factors after treatment of oligometastatic non-small-cell lung cancer.

Umberto Ricardi, Suresh Senan, Giulio Melloni, 2014, Clinical lung cancer.

Spinal Drop Metastasis in Myxopapillary Ependymoma: A Case Report and a Review of Treatment Options

K. Walter, T. Lundquist, M. Milano, 2014, Rare tumors.

Inoperable Pulmonary Carcinoid Tumors: Local Control Rates With Stereotactic Body Radiotherapy/Hypofractionated RT With Image-Guided Radiotherapy.

Deepinder P. Singh, Yuhchyau Chen, M. Milano, 2019, Clinical lung cancer.

Srinivasan Vijayakumar, J. Kao, A. Jani, 2003 .

Intensity-modulated radiation therapy (IMRT) in the treatment of anal cancer: toxicity and clinical outcome.

Ashesh B Jani, Steven J Chmura, Ruth Heimann, 2005, International journal of radiation oncology, biology, physics.

Classification for long-term survival in oligometastatic patients treated with ablative radiotherapy: A multi-institutional pooled analysis

Julian C. Hong, R. Weichselbaum, J. Kao, 2018, PloS one.

Chapter 14 – Late Effects after Radiation

L. Constine, L. Marks, M. Milano, 2016 .

Chapter 13 – Survivorship and Late Effects

L. Constine, L. Marks, M. Milano, 2011 .

Primary spinal cord glioma: a Surveillance, Epidemiology, and End Results database study

Mahlon D. Johnson, K. Walter, D. Korones, 2010, Journal of Neuro-Oncology.

Cellular Response to DNA Damage

J. Kao, B. Rosenstein, S. Kron, 2005, Annals of the New York Academy of Sciences.

Intensity-modulated radiotherapy in treatment of pancreatic and bile duct malignancies: toxicity and clinical outcome.

J. Roeske, A. Jani, M. Milano, 2004, International journal of radiation oncology, biology, physics.

Radical irradiation of extracranial oligometastases.

M. Milano, J. Salama, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Intensity-modulated radiation therapy in the treatment of gastric cancer: early clinical outcome and dosimetric comparison with conventional techniques.

K. Farrey, A. Jani, M. Milano, 2006, The British journal of radiology.

Big Data Approaches to Improve Stereotactic Body Radiation Therapy (SBRT) Outcomes: Big Data for SBRT

Eduardo G. Moros, Joseph O. Deasy, Nitin Ohri, 2018 .

Radiotherapy for Oligometastatic Lung Cancer

Deepinder P. Singh, M. Milano, S. Chmura, 2017, Front. Oncol..

Thoracic malignant solitary fibrous tumors: A population-based study of survival.

Deepinder P. Singh, Hong Zhang, M. Milano, 2011, Journal of thoracic disease.

Survival of Patients With Second Primary Hodgkin Lymphoma.

L. Constine, M. Milano, C. Doucette, 2020, Clinical lymphoma, myeloma & leukemia.

Advances in Chemoradiation Treatment of Locoregionally Advanced Non–Small Cell Lung Cancer

Yuhchyau Chen, M. Milano, 2007 .

New prospects for management and treatment of inoperable and recurrent skull base meningiomas

Mahlon D. Johnson, S. Toms, M. Milano, 2007, Journal of Neuro-Oncology.

NRG BR002: A phase IIR/III trial of standard of care therapy with or without stereotactic body radiotherapy (SBRT) and/or surgical ablation for newly oligometastatic breast cancer.

Martha M. Matuszak, Hania A. Al-Hallaq, Hanna Bandos, 2015 .

NRG-BR002: A phase IIR/III trial of standard of care systemic therapy with or without stereotactic body radiotherapy (SBRT) and/or surgical resection (SR) for newly oligometastatic breast cancer (NCT02364557).

W. Woodward, H. Al-Hallaq, Benjamin D. Smith, 2022, Journal of Clinical Oncology.

Nodular Leptomeningeal Disease - A Distinct Pattern of Recurrence After Post-Resection Stereotactic Radiosurgery for Brain Metastases: A Multi-Institutional Study of Inter-Observer Reliability.

P. Brown, James D. Murphy, N. Fischbein, 2018, International journal of radiation oncology, biology, physics.

A prospective pilot study of curative‐intent stereotactic body radiation therapy in patients with 5 or fewer oligometastatic lesions

M. Schell, A. Muhs, P. Okunieff, 2008, Cancer.

Intensity-modulated radiation therapy in advanced head and neck patients treated with intensive chemoradiotherapy: preliminary experience and future directions.

R. Weichselbaum, E. Vokes, D. Haraf, 2006, International journal of oncology.

Brain metastasis from melanoma: the prognostic value of varying sites of extracranial disease

K. Walter, P. Okunieff, K. Usuki, 2015, Journal of Neuro-Oncology.

Stereotactic Radiosurgery for Vestibular Schwannomas: Tumor Control Probability Analyses and Recommended Reporting Standards.

E. Yorke, T. Solberg, J. Adler, 2020, International journal of radiation oncology, biology, physics.

Oligometastatic breast cancer treated with hypofractionated stereotactic radiotherapy: Some patients survive longer than a decade.

P. Okunieff, Hong Zhang, M. Milano, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Impact of Right-sided Primary Tumor Location Among Patients With Oligometastatic Colorectal Cancer Treated With Stereotactic Body Radiotherapy

K. Usuki, M. Milano, A. Katz, 2018, American journal of clinical oncology.

Stereotactic body radiotherapy for treatment of adrenal metastases.

A. Muhs, Yuhchyau Chen, P. Okunieff, 2009, International journal of radiation oncology, biology, physics.

Multicenter results of stereotactic body radiotherapy (SBRT) for non-resectable primary liver tumors

Charles M. Miller, J. Sanabria, K. Goodman, 2012, Acta oncologica.

Stereotactic hypofractionated radiation therapy as a bridge to transplantation for hepatocellular carcinoma: clinical outcome and pathologic correlation.

A. Hezel, M. Milano, A. Katz, 2012, International journal of radiation oncology, biology, physics.

SBRT for Hepatocellular Carcinoma: 8-Year Experience from a Regional Transplant Center

K. Usuki, M. Milano, A. Katz, 2018, Journal of Gastrointestinal Cancer.

Normal tissue tolerance dose metrics for radiation therapy of major organs.

L. Constine, P. Okunieff, M. Milano, 2007, Seminars in radiation oncology.

Solid tumors after chemotherapy or surgery for testicular nonseminoma: a population-based study.

S. Fosså, C. Fung, L. Travis, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The evolving role of radiotherapy in treatment of oligometastatic NSCLC

Deepinder P. Singh, M. Milano, S. Chmura, 2015, Expert review of anticancer therapy.

Time to treatment initiation and outcomes in high-grade glioma patients in rehabilitation: a retrospective cohort study

M. Strawderman, K. Walter, N. Mohile, 2020, CNS oncology.

Second primary breast cancer after diagnosis of breast cancer among male patients: An examination of population characteristics and overall survival

M. Milano, M. Shayne, D. N. Chowdhry, 2020, EClinicalMedicine.

Multicentre results of stereotactic body radiotherapy for secondary liver tumours.

Charles M. Miller, J. Sanabria, K. Goodman, 2013, HPB : the official journal of the International Hepato Pancreato Biliary Association.

Second Primary Non-Small-Cell Lung Cancer After Head and Neck Cancer: A Population-Based Study of Clinical and Pathologic Characteristics and Survival Outcomes in 3597 Patients.

Deepinder P. Singh, M. Milano, N. Denunzio, 2020, Clinical lung cancer.

Second primary lung cancer after head and neck squamous cell cancer: Population‐based study of risk factors

Deepinder P. Singh, Yuhchyau Chen, Hong Zhang, 2012, Head & neck.

Secondprimarylungcancerafterheadandnecksquamouscellcancer:Population-based study of risk factors

Deepinder P. Singh, Yuhchyau Chen, Hong Zhang, 2012 .

Oligoprogression in non-small cell lung cancer: a narrative review

Deepinder P. Singh, M. Milano, Haoming Qiu, 2022, Journal of thoracic disease.

Defining the role of curative local therapy in oligometastatic cancer: a new era.

S. Lo, M. Milano, T. Biswas, 2021, Annals of Palliative Medicine.

Technical challenges of linac-based stereotactic ablative body radiotherapy: short review for non-radiation oncologists.

M. Milano, A. Mihai, L. Rock, 2020, Annals of palliative medicine.

Radiation-Induced Inferior Brachial Plexopathy after Stereotactic Body Radiotherapy: Pooled Analyses of Risks.

E. Yorke, L. Marks, A. Mahadevan, 2023, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Organs at Risk Considerations for Thoracic Stereotactic Body Radiation Therapy: What Is Safe for Lung Parenchyma?

E. Yorke, M. Martel, X. Li, 2018, International journal of radiation oncology, biology, physics.

The utilization patterns and comparative effectiveness of systemic therapy with high-dose thoracic radiotherapy or low-dose thoracic radiotherapy versus systemic therapy alone in newly diagnosed metastatic non-small cell lung cancer patients

Deepinder P. Singh, M. Milano, J. Bates, 2019, Journal of Radiation Oncology.

Commercial Insurance Coverage of Advanced Radiotherapy Techniques Compared to American Society for Radiation Oncology Model Policies.

Joe Y. Chang, J. Welsh, Steven H. Lin, 2020, Practical radiation oncology.

Stereotactic body radiotherapy in patients with multiple lung tumors: a focus on lung dosimetric constraints

Deepinder P. Singh, Yuhchyau Chen, F. Kong, 2019, Expert review of anticancer therapy.

Signals from SABR-COMET time to move on to phase III studies.

M. Milano, S. Chmura, J. Salama, 2019, Annals of translational medicine.

Comparison of outcomes in patients with stage III versus limited stage IV non-small cell lung cancer

P. Okunieff, Yuhchyau Chen, M. Milano, 2011, Radiation oncology.

Stereotactic radiosurgery and hypofractionated stereotactic radiotherapy: normal tissue dose constraints of the central nervous system.

M. Schell, D. Clark, K. Walter, 2011, Cancer treatment reviews.

Single- and Multifraction Stereotactic Radiosurgery Dose/Volume Tolerances of the Brain.

E. Yorke, A. Niemierko, L. Marks, 2020, International journal of radiation oncology, biology, physics.

Split-Course Palliative Radiotherapy for Advanced Non-small Cell Lung Cancer

P. Rubin, Yuhchyau Chen, M. Milano, 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Beneficial Effects of Radiation-Induced Autoantibody on Clinical Outcomes after Stereotactic Radiotherapy for Metastatic Breast Cancer

P. Okunieff, H. Ishikawa, T. Nakano, 2012 .

Radiation-Induced Edema After Single-Fraction or Multifraction Stereotactic Radiosurgery for Meningioma: A Critical Review.

I. El Naqa, A. Sahgal, S. Soltys, 2018, International journal of radiation oncology, biology, physics.

Nodular Leptomeningeal Disease – A Distinct Pattern of Recurrence after Post-Resection Stereotactic Radiosurgery for Brain Metastases: A Multi-Institutional Study of Inter-Observer Reliability

P. Brown, N. Fischbein, S. Lo, 2018, International Journal of Radiation Oncology*Biology*Physics.

Radiotherapy for Brain Metastases From Renal Cell Carcinoma in the Targeted Therapy Era: The University of Rochester Experience

K. Walter, P. Okunieff, K. Usuki, 2017, American journal of clinical oncology.

Patterns and timing of recurrence after temozolomide-based chemoradiation for glioblastoma.

K. Walter, D. Korones, N. Mohile, 2010, International journal of radiation oncology, biology, physics.

Spurious progression in pediatric brain tumors

S. Ekholm, L. Constine, A. Muhs, 2012, Journal of Neuro-Oncology.

The IMPACT of Molecular Grading of Gliomas on Contemporary Clinical Practice.

S. Soltys, K. Redmond, G. Minniti, 2020, International journal of radiation oncology, biology, physics.

Stereotactic radiosurgery for glioblastoma: retrospective analysis

Tithi Biswas, Paul Okunieff, P. Okunieff, 2009, Radiation oncology.

Correlation between progression free survival and dynamic susceptibility contrast MRI perfusion in WHO grade III glioma subtypes

S. Ekholm, K. Walter, D. Korones, 2013, Journal of Neuro-Oncology.

Executive summary of american radium society's appropriate use criteria for the postoperative management of lower grade gliomas.

A. Garg, M. Ahluwalia, S. Lo, 2022, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Variables affecting survival after second primary lung cancer: A population-based study of 187 Hodgkin's lymphoma patients.

L. Constine, L. Travis, M. Milano, 2012, Journal of thoracic disease.

Survival after second primary lung cancer

L. Constine, L. Travis, M. Milano, 2011, Cancer.

A registry-based analysis of survival outcomes in mast cell leukemia.

M. Milano, J. Budnik, 2019, Leukemia research.

Normal tissue toxicity after small field hypofractionated stereotactic body radiation

L. Constine, P. Okunieff, M. Milano, 2008, Radiation oncology.

Age and Racial Differences among PSA-Detected (AJCC Stage T1cN0M0) Prostate Cancer in the U.S.: A Population-Based Study of 70,345 Men

E. Messing, R. Chen, O. Hyrien, 2013, Front. Oncol..

Prognostic Significance of Sites of Visceral Metastatic Disease in Prostate Cancer: A Population-based Study of 12,180 Patients.

M. Milano, K. Bylund, J. Bates, 2019, Clinical genitourinary cancer.

Cardiovascular Disease Mortality After Chemotherapy or Surgery for Testicular Nonseminoma: A Population-Based Study.

Derick R. Peterson, S. Fosså, C. Fung, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cognitive and neuroimaging outcomes in individuals with benign and low-grade brain tumours receiving radiotherapy: a protocol for a prospective cohort study

Jianhui Zhong, G. Schifitto, N. Mohile, 2023, BMJ Open.

Prognostic significance of sites of extrathoracic metastasis in patients with non-small cell lung cancer.

M. Milano, J. Bates, 2017, Journal of thoracic disease.

NRG-BR002: A phase IIR/III trial of standard of care therapy with or without stereotactic body radiotherapy (SBRT) and/or surgical ablation for newly oligometastatic breast cancer (NCT02364557).

W. Woodward, H. Al-Hallaq, M. Matuszak, 2019, Journal of Clinical Oncology.

Patient Exposure from Radiologic and Nuclear Medicine Procedures in the United States: Procedure Volume and Effective Dose for the Period 2006-2016.

Donald L. Miller, F. Mettler, D. Frush, 2020, Radiology.

Histology-Specific Metastasis

M. Milano, J. Salama, 2011 .

Patient Radiation Exposure: Imaging During Radiation Oncology Procedures: Executive Summary of NCRP Report No. 184.

F. Mettler, M. Mahesh, M. Milano, 2020, Journal of the American College of Radiology : JACR.

New dosimetric guidelines for linear Boltzmann transport equations through comparative evaluation of stereotactic body radiation therapy for lung treatment planning

Deepinder P. Singh, L. Constine, Yuhchyau Chen, 2021, Journal of applied clinical medical physics.

Spinal cord dose tolerance to stereotactic body radiotherapy.

E. Yorke, A. Niemierko, Lijun Ma, 2019, International journal of radiation oncology, biology, physics.

Solid and Hematologic Neoplasms After Testicular Cancer: A US Population-Based Study of 24 900 Survivors

S. Fosså, D. Feldman, P. Monahan, 2020, JNCI cancer spectrum.

Long-term CT surveillance after primary lung cancer treatment captures events in all risk groups.

John Kang, M. Milano, A. Chowdhry, 2018, Translational lung cancer research.

Non–Small-Cell Lung Cancer After Breast Cancer: A Population-Based Study of Clinicopathologic Characteristics and Survival Outcomes in 3529 Women

R. Strawderman, L. Travis, M. Milano, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Reply to G. Gandaglia et al.

S. Fosså, C. Fung, L. Travis, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Stereotactic Body Radiation Therapy for Spinal Metastases: Tumor Control Probability Analyses and Recommended Reporting Standards.

E. Yorke, Y. Yamada, X. Li, 2021, International journal of radiation oncology, biology, physics.

Comparison between closed pleural biopsy and medical thoracoscopy for the diagnosis of undiagnosed exudative pleural effusions: a systematic review and meta-analysis

Yuqing Wei, K. Shen, T. Lv, 2020, Translational lung cancer research.

Septins disruption controls tumor growth and enhances efficacy of Herceptin

Richard G. Moore, Jason R. Myers, C. Laggner, 2020, bioRxiv.

Second Primary Non–Small Cell Lung Cancer after Head and Neck Cancer: A Population-Based Study of Clinical and Pathologic Characteristics and Survival Outcomes in 3597 Patients

Deepinder P. Singh, M. Milano, J. Budnik, 2017 .

Stereotactic Body Radiation for the Spine: A Review

M. Schell, M. Milano, Sheema Chawla, 2013, American journal of clinical oncology.

A Systematic Review and Meta-Analysis of Liver Tumor Position Variability during SBRT using Various Motion Management and IGRT Strategies.

O. Morin, M. Feng, M. Milano, 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Intensity-modulated versus conventional pelvic radiotherapy for prostate cancer: analysis of acute toxicity.

A. Su, A. Jani, M. Milano, 2006, Urology.

Review of thoracic reirradiation with stereotactic body radiation therapy: A focus on toxicity risks.

F. Kong, M. Milano, A. Mihai, 2018, Practical radiation oncology.

Stereotactic Body Radiotherapy for Oligometastasis: Opportunities for Biology to Guide Clinical Management

D. Palma, M. Milano, J. Salama, 2016, Cancer journal.

Identification of a Vitamin-D Receptor Antagonist, MeTC7, which Inhibits the Growth of Xenograft and Transgenic Tumors In Vivo

Richard G. Moore, P. Jurutka, N. Dokholyan, 2022, Journal of medicinal chemistry.

Definitive radiotherapy for stage I nonsmall cell lung cancer

Deepinder P. Singh, Yuhchyau Chen, K. Usuki, 2012, Cancer.

Changes in relative cerebral blood volume 1 month after radiation-temozolomide therapy can help predict overall survival in patients with glioblastoma.

Jianhui Zhong, S. Ekholm, J. Zhong, 2010, Radiology.

Treatment completion, treatment compliance and outcomes of old and very old patients treated by dose adapted stereotactic ablative radiotherapy (SABR) for T1-T3N0M0 non-small cell lung cancer.

R. McDermott, M. Milano, J. Armstrong, 2019, Journal of geriatric oncology.

Second Course of Radiation for New Primary Head-and-Neck Cancer: Population-Based Study of Survival

Hong Zhang, M. Milano, 2011, American journal of clinical oncology.

Patterns of Recurrence After Curative-Intent Radiation for Oligometastases Confined to One Organ

P. Okunieff, M. Milano, A. Katz, 2009, American journal of clinical oncology.

Stroke death in patients receiving radiation for head and neck cancer in the modern era

Deepinder P. Singh, Yuhchyau Chen, N. Mohile, 2023, Frontiers in Oncology.

Dose-Response Model for Chest Wall Tolerance of Stereotactic Body Radiation Therapy.

Vitali Moiseenko, Jesse McKay, Jimm Grimm, 2016, Seminars in radiation oncology.

Dose-Volume Predictors of Radiation Pneumonitis After Lung Stereotactic Body Radiation Therapy (SBRT): Implications for Practice and Trial Design

E. Yorke, K. Forster, A. Jackson, 2020, Cureus.

Long-term survival among Hodgkin's lymphoma patients with gastrointestinal cancer: a population-based study.

M. Stovall, L. Constine, H. Li, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Primary Hypothyroidism in Childhood Cancer Survivors Treated With Radiation Therapy: A PENTEC Comprehensive Review.

E. Yorke, C. Ronckers, L. Constine, 2021, International journal of radiation oncology, biology, physics.

Intensity modulated radiation therapy and the internet: Evaluation of the content and quality of patient-oriented information

J. Roeske, L. Mell, A. Mundt, 2004 .

Risk of brain metastases in T1–3N0 NSCLC: a population-based analysis

K. Usuki, M. Milano, M. Cummings, 2020, Lung cancer management.

Hypofractionated Stereotactic Radiation Therapy Dosimetric Tolerances for the Inferior Aspect of the Brachial Plexus: A Systematic Review.

E. Yorke, L. Marks, A. Mahadevan, 2023, International journal of radiation oncology, biology, physics.

Late Toxicity from Hypofractionated Stereotactic Body Radiation

L. Constine, P. Okunieff, M. Milano, 2008 .

Novel Applications of Stereotactic Radiosurgery Beyond Oncology: Prospective Trials in Functional Radiosurgery.

S. Soltys, D. Trifiletti, J. Hattangadi-Gluth, 2023, International journal of radiation oncology, biology, physics.

Reply to S. Alanee et al.

S. Fosså, C. Fung, L. Travis, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Simple Clinical Factors Associated With Radiation-Induced Lung Toxicity After Stereotactic Body Radiation Therapy in Lung Cancer: A Pooled Analysis of 70 Studies

E. Yorke, B. Kavanagh, F. Kong, 2014 .

Twice-daily re-irradiation of recurrent and second primary head and neck cancer with gemcitabine, paclitaxel and fluorouracil chemoradiotherapy.

R. Weichselbaum, E. Vokes, D. Haraf, 2004, Journal of Clinical Oncology.

Time to Treatment Initiation and Clinical Outcomes in High-Grade Glioma Patients Admitted to Inpatient Rehabilitation: A Retrospective Study

M. Strawderman, K. Walter, N. Mohile, 2019 .

Understanding and Predicting Radiation-Associated Normal Tissue Injury: A Global and Historical Perspective

P. Rubin, L. Marks, M. Milano, 2014 .

A population-based study of prognosis and survival in patients with second primary thyroid cancer after Hodgkin lymphoma

L. Constine, C. Fung, M. Milano, 2018, Leukemia & lymphoma.

Clinical Efficacy of Tumor Treating Fields for Newly Diagnosed Glioblastoma

M. Strawderman, K. Walter, N. Mohile, 2020, AntiCancer Research.

Phase I Trial of Stereotactic Body Radiation Therapy (SBRT) to Multiple Metastatic Sites: A NRG Oncology Study

H. Al-Hallaq, T. Pisansky, M. Matuszak, 2018, International Journal of Radiation Oncology*Biology*Physics.

The Impact of GM-CSF Up-regulation by SBRT on Overall Survival of Metastatic Breast Cancer Patients

H. Ishikawa, Lurong Zhang, P. Okunieff, 2009 .

Stereotactic radiosurgery for spinal metastases: case report and review of treatment options.

P. Okunieff, T. Lundquist, M. Milano, 2009, Bone.

The Art of Radiation Therapy: The Necessary Risk of Radiation Necrosis for Durable Control of Brain Metastases.

E. Yorke, D. Heron, R. Timmerman, 2022, International journal of radiation oncology, biology, physics.

A Dose of Reality: Embracing the Unseen to Improve Stereotactic Radiotherapy.

M. Katz, M. Milano, A. Mihai, 2022, Clinical oncology (Royal College of Radiologists (Great Britain)).

A Primer on Dose-Response Data Modeling in Radiation Therapy.

E. Yorke, I. El Naqa, L. Marks, 2020, International journal of radiation oncology, biology, physics.

An individual patient data metaanalysis of outcomes and prognostic factors after treatment of oligometastatic non-small-cell lung cancer.

D. Gomez, G. Melloni, S. Senan, 2014, Clinical lung cancer.

Back to the Future: Charting the Direction of Lower Grade Glioma Trials With Lessons From the Present and Past

S. Soltys, K. Redmond, D. Trifiletti, 2022, International Journal of Radiation Oncology*Biology*Physics.

The Impact of Timing of Concurrent Chemoradiation in Patients With High-Grade Glioma in the Era of the Stupp Protocol

K. Walter, M. Milano, Yang Liu, 2019, Front. Oncol..

Five-year follow-up after stereotactic body radiotherapy for medically inoperable early-stage non-small cell lung cancer: a multicenter study

T. Sio, L. Xing, M. Milano, 2023, Translational lung cancer research.

Stereotactic Body Radiation Therapy for Oligometastatic Renal Cell Carcinoma or Melanoma: Prognostic Factors and Outcomes

Deepinder P. Singh, R. Brasacchio, Yuhchyau Chen, 2015 .

Impact of radiotherapy on laryngeal cancer survival

R. Chen, O. Hyrien, Yuhchyau Chen, 2012, Cancer.

International consensus on radiotherapy in metastatic non-small cell lung cancer

Joe Y. Chang, Wei Zhou, D. Ruysscher, 2021, Translational lung cancer research.

Treatment Planning Expansions in Glioblastoma: How Less Can Be More.

E. Pollom, D. Trifiletti, J. Hattangadi-Gluth, 2023, International journal of radiation oncology, biology, physics.

Non–Small-Cell Lung Cancer After Breast Cancer: A Population-Based Study of Clinicopathologic Characteristics and Survival Outcomes in 3529 Women

R. Strawderman, L. Travis, M. Milano, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Retinopathy, Optic Neuropathy, and Cataract in Childhood Cancer Survivors Treated With Radiation Therapy: A PENTEC Comprehensive Review.

L. Constine, S. Kry, I. Vogelius, 2023, International journal of radiation oncology, biology, physics.

Impact of Radiotherapy on Laryngeal Cancer Survival: A Population-based Study of 13,808 U.S. Patients

R. Chen, O. Hyrien, Yuhchyau Chen, 2011 .

Stereotactic body radiotherapy for treatment of adrenal metastases.

A. Muhs, Yuhchyau Chen, P. Okunieff, 2009, International journal of radiation oncology, biology, physics.

Oral Abstract PresentationAn Individual Patient Data Meta-Analysis of Outcomes and Prognostic Factors After Treatment of Oligometastatic Non-Small Cell Lung Cancer: Metastatic Non-Small Cell Lung Cancer

D. Gomez, G. Melloni, S. Senan, 2014 .

Malignant Pleural Mesothelioma: A Population-Based Study of Survival

Hong Zhang, M. Milano, 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.